Corporate Development

Teleflex Incorporated has grown over its 65-year history with new products, by entering new geographical markets, and through acquisitions. In the past two years, Teleflex completed four acquisitions with a total value of more than $2 billion and three divestitures worth approximately $1 billion. Since 1990, Teleflex has completed more than 100 transactions.

The Teleflex Corporate Development team is particularly interested in partnership and acquisition opportunities that can strengthen our global leadership in medical disposables. Our key criteria are:

Products

• Medical disposables with medium complexity (FDA Class I and II)
• Fit within Teleflex Medical’s existing focus areas and call-points:
  • Venous Access
  • Specialty Catheters
  • Anesthesia
  • Urology
  • Respiratory
  • Surgical
  • OEM
• Fit with Teleflex Medical’s mission:

“Enhance patient outcomes with products that are less invasive, reduce infections, and improve patient safety.”

Financial

• Proven products with actual revenues
• EBITDA: $0 - $30 million

If you have a business or product that fits the above parameters, and you are interested in exploring opportunities with Teleflex, please contact us through the link highlighted below.

Contact Corporate Development Office

Teleflex Medical Acquisitions